Greenstone launches authorized Tikosyn generic

PEAPACK, N.J. — Greenstone on Friday announced the introduction of its authorized generic of Tikosyn (dofetilide) capsules. The drug is indicated for the maintenance of normal sinus rhythm in patients with atrial fibrillation/atrial flutter of greater than one week who have been converted to normal sinus rhythm. 

 

Greenstone's dofetilide will be available in 60-count bottles of 0.125-, 0.250- and 0.5-mg dosage strength capsules.